Actively Recruiting
Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
Led by Charite University, Berlin, Germany · Updated on 2025-02-13
200
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
Sponsors
C
Charite University, Berlin, Germany
Lead Sponsor
B
Bielefeld University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.
CONDITIONS
Official Title
Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with restrictive or bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)
- Meets inpatient treatment indication according to S3 guideline
- Weight below 3rd BMI percentile, or weight below 10th percentile with psychiatric comorbidity, rapid weight loss, or lack of weight gain in last 3 months
- Planned inpatient treatment
- Insured with one of the participating health insurance companies
- Has a stable internet connection
You will not qualify if you...
- Weight below 67% median BMI
- Acute self-harm or danger to others
- Acute psychosis or suicidal tendencies
- Current substance abuse
- Child abuse or domestic violence in the family
- Insured with a health insurance company not participating in the study
- Judicial placement order for inpatient treatment
- Known current child protection issues or family court proceedings
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Charité- Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 13353
Actively Recruiting
Research Team
V
Verena K. Haas, Dr. oec. troph.
CONTACT
P
Piet E. Adler, M.Sc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here